Pancreatic adenocarcinoma, TNBC (ER+/HER2- subtype), Bladder cancer with non-muscle invasive and low tumor mutational burden, glioblastomas with highly immunosuppressive TME, low tumor mutational burden. This evidence concerns the gene ERBB2 and urinary bladder cancer.